BHC
$31.42
Bausch Health Companies
$.14
.45%
BHC
Earnings Whisper ®
N/A
1st Quarter March 2021
Consensus: $0.95
Revenue: $2.06 Bil
Wednesday
May 26
7:00 AM ET
Guidance announcement made Wednesday, February 24, 2021
Latest EPS
Wednesday, February 24, 2021
What do you expect when BHC reports earnings?
Where is BHC's stock price going from here?
Analysts
Pivots
Resistance
$33.23
$32.55
$31.99
Support
$30.74
$30.06
$29.50
Description
Bausch Health Companies Inc. develops and distributes drugs. It develops drugs for unmet medical needs in central nervous system disorders and distributes generic and branded generic drugs primarily in Latin America and Eastern Europe. Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals, is based in NJ, United States.
